[1]邱新文,任旋,兰丽霞,等.光学相干断层扫描血管成像引导光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变[J].眼科新进展,2019,39(8):767-771.[doi:10.13389/j.cnki.rao.2019.0175]
　QIU Xin-Wen,REN Xuan,LAN Li-Xia,et al.Photodynamic therapy guided by optical coherence tomography angiography for treatment of chronic central serous chorioretinopathy[J].Recent Advances in Ophthalmology,2019,39(8):767-771.[doi:10.13389/j.cnki.rao.2019.0175]
点击复制

光学相干断层扫描血管成像引导光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
39卷
期数:
2019年8期
页码:
767-771
栏目:
应用研究
出版日期:
2019-08-05

文章信息/Info

Title:
Photodynamic therapy guided by optical coherence tomography angiography for treatment of chronic central serous chorioretinopathy
作者:
邱新文; 任旋; 兰丽霞; 邱丘; 叶波
330002　江西省南昌市，南昌爱尔眼科医院眼底病科
Author(s):
QIU Xin-Wen; REN Xuan; LAN Li-Xia; QIU Qiu; YE Bo
Department of Fundus Diseases，Nanchang Aier Eye Hospital，Nanchang 330002，Jiangxi Province，China
关键词:
荧光素眼底血管造影; 吲哚菁绿血管造影; 光学相干断层扫描血管成像; 光动力疗法; 中心性浆液性脉络膜视网膜病变
Keywords:
fundus fluorescence angiography; indocyanine green angiography; optical coherence tomography angiography; photodynamic therapy; central serous chorioretinopathy
分类号:
R774.5
DOI:
10.13389/j.cnki.rao.2019.0175
文献标志码:
A
摘要:
目的　探讨光学相干断层扫描血管成像（optical coherence tomography angiography，OCTA）作为一种新方法引导光动力疗法（photodynamic therapy，PDT）治疗慢性中心性浆液性脉络膜视网膜病变（central serous chorioretinopathy，CSC）的疗效。方法　非随机病例对照研究。慢性CSC患者60例（60眼），按引导PDT光斑设计方法分为三组，每组各20例，A组由荧光素眼底血管造影设计、B组由吲哚菁绿血管造影设计、C组由OCTA设计，同时选入正常眼36例（36眼）作为对照；患者均采用半剂量维替泊芬PDT进行治疗。比较治疗前后不同时期最佳矫正视力（best corrected visual acuity，BCVA）、视网膜下液（subretinal fluid，SRF）吸收时间、光感受器内外节至Bruch膜厚度（photoreceptor inner/outer segment to bruch member thickness，IOBT）、中央视网膜厚度（central retinal thickness，CRT）、黄斑中心凹下脉络膜厚度（subretinal fovea choridial thickness，SFCT）、后极部6 mm×6 mm区域脉络膜毛细血管血流密度（choriocapillary layer angio-flow density，CFD）以及治疗后并发症情况。结果　PDT光斑大小A组（1500.00±79.47）μm、B组（2800.00±629.95）μm、C组（2700.00±553.46）μm差异有统计学意义（P=0.000），A组明显小于B、C组（均为P=0.000），B、C两组差异无统计学意义（P=0.358）。三组SRF吸收时间差异有统计学意义（P=0.000），其中A组比B、C组时间延长（均为P=0.000），B、C组差异无统计学意义（P=0.151）。SRF吸收后三组BCVA 显著提高、IOBT显著增厚，差异均有统计学意义（均为P=0.000），三组间BCVA差异无统计学意义（P=0.176）、IOBT差异有统计学意义（P=0.041）。SRF吸收后三组CRT、SFCT与CFD明显降低,差异均有统计学意义（均为P=0.000），三组间CRT、CFD差异均有统计学意义（均为P=0.000），但SFCT差异无统计学意义（P=0.245）。CSC患者治疗前后BCVA、CRT、SFCT、IOBT以及治疗前CFD与正常眼差异均有统计学意义（均为P<0.05）。治疗后未见与视力相关的眼部及全身并发症。结论　适当大小PDT光斑有利于缩短CSC病程，但对最终视力影响不大；OCTA引导与FFA、ICGA引导PDT治疗CSC有相似的效果；因为无创及经济，OCTA引导更优于FFA及ICGA引导。
Abstract:
Objective　To explore the effect of optical coherence tomography angiography (OCTA) as a new technique to guide photodynamic therapy (PDT) in the treatment of chronic central serous chorioretinopathy (CSC).Methods　A non-randomized case-control study.Sixty patients (60 eyes) with chronic CSC were divided into three groups according to the guiding PDT spot design method,20 patients in each group.Group A was designed by fluorescence angiography,group B was designed by indocyanine green angiography,and group C was designed by OCTA.At the same time,36 normal patients (36 eyes) were selected as the control group.All patients were treated by PDT with half-dose verteporfin.The best corrected visual acuity (BCVA),subretinal fluid (SRF) disappearance time,photoreceptor inner/outer segment to bruch member thickness (IOBT)，central retinal thickness (CRT),subretinal fovea choridial thickness(SFCT),choriocapillary layer angi-flow density (CFD) on 6 mm×6 mm region of the posterior pole and postoperative complications were compared and analyzed before and after PDT treatment.Results　There were significant differences between group A ［(1500.00±79.47)μm］,group B ［(2800.00±629.95)μm］,and group C ［(2700.00±553.46)μm］ in PDT treatment spot (P=0.000),the treatment spot of group A was significantly smaller than group B and group C (both P=0.000),and there was no significant difference between group B and group C (P=0.358).SRF absorption time of the three groups was significantly different (P=0.000),in which the time of group A was longer than that of group B and group C (both P=0.000),while the time of group B and group C was not significantly different(P=0.151).After SRF absorption,BCVA was significantly increased in the three groups (all P=0.000),IOBT was significantly increased and structure was improved(all P=0.000),there was no significant difference in BCVA(P=0.176) and was significantly different in IOBT between the three groups(P=0.041).After SRF absorption,CRT,SFCT and CFD were significantly reduced in the three groups (all P=0.000),and there were significant differences in CRT and CFD among the three groups (all P=0.000),but no significant differences in SFCT (P=0.245).There were significant differences in BCVA,CRT,SFCT,IOBT and CFD between CSC patients and normal eyes before and after treatment (all P<0.05).No ocular or systemic complications related to visual acuity were observed after treatment.Conclusion　PDT with appropriate spot can shorten the course of CSC but has little effect on the final vision.OCTA guidance has similar effect with FFA and ICGA-guided PDT in the treatment of CSC.Because of noninvasive and economical,OCTA guidance is superior to FFA and ICGA guidance.

参考文献/References:

［1］　WANG M，MUNCH I C，HASLER P W，PRUNTE C，LARSEN M.Central serous chorioretinopathy［J］.Acta Ophthalmol，2008，86（2）：126-145.
［2］　GEMENETZI M，SALVO G D，LOTERY A J.Central serous cho-rioretinopathy：an update on pathogenesis and treatment［J］.Eye，2010，24（12）：1743-1756.
［3］　LEE S T，ADELMAN R A.The treatment of recurrent central serous chorioretinopathy with intravitreal bevacizumab［J］.J Ocul Pharmacol Ther，2011，27（6）：611-614.
［4］　LAI F H，NG D S，BAKTHAVATSALAM M，CFAN V C，YOUNG A，OJLUK F，et al.A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous chorioretinopathy ［J］.Am J Ophthalmol，2016，170（10）：91-99.
［5］　YANNUZZI L A，SLAKTER J S，GROSS N E，SPAIDE R F，COSTA D L，HUANG S J，et al.Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy：a pilot study ［J］.Retina，2003，23（6）：288-298.
［6］　KOYTAK A，EROL K，COSKUN E，ASIK N，OZTURK H，OZERTURK Y.Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for central serous chorioretinopathy［J］.Retina，2010，30（10）：1698-1703.
［7］　CHAN S Y，WANG Q，WEI W，JONAS J B.Optical coherence tomographic angiography in central serous chorioretinopathy［J］.Retina，2016，36（11）：2051-2058.
［8］　MO B，ZHOU H Y，JIAO X，LIU W.Comparative study of optical coherence tomography angiography and ICGA in central serous chorioretinopathy ［J］.Int Eye Sci，2017，17（7）：1351-1355.
莫宾，周海英，焦璇，刘武.中心性浆液性脉络膜视网膜病变的OCTA特点及ICGA的比较分析［J］.国际眼科杂志，2017，17（7）：1351-1355.
［9］　SU W Q，HU L Y，LI X R，LI Z Q.Clinical study of compound anisodine injection in the treatment of chronic central serous chorioretinopathy［J］.Rec Adv Ophthalmol，2018，38（12）：1137-1140.
苏雯琪，胡立影，李筱荣，李志清.复方樟柳碱注射液治疗慢性中心性浆液性脉络膜视网膜病变的临床研究［J］.眼科新进展，2018，38（12）：1137-1140.
［10］　CHAN W M，LAI T Y，LAI R Y，TANG E W，LIU D T，LAM D S.Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy：one-year results of a prospective study［J］.Retina，2008，28（1）：85-93.
［11］　KIM Y K，RYOO N K，WOO S J，PARK K H.Choroidal thickness changes after photodynamic therapy and recurrence of chronic central serous chorioretinopathy［J］.Am J Ophthalmol，2015，160（1）：72-84.
［12］　ZENG J，YAN Y Y，DING X Y，LIU R，LI J Q.Choridal thickness after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinpathy［J］.Chin J Ophthalmol，2013，49（6）：490-494.
曾婧，闫媛媛，丁小燕，刘冉，李加青.半剂量光动力疗法治疗后慢性中心性浆液性脉络膜视网膜病变患者脉络膜厚度变化分析［J］.中华眼科杂志，2013，49（6）：490-494.
［13］　JIAO Y，FU B B，YE B，HUANG Y H，ZHANG H，HE W S，et al.Clinical observation of optical coherence tomography angiography in the macular vascular density after repair of retinal detachment［J］.Rec Adv Ophthalmol，2018，38（4）：373-377.
焦亚，付碧波，叶波，黄银花，章晖，贺文山，等.视网膜脱离复位术后黄斑区血流密度：基于光学相干断层扫描血管成像（OCTA）的观察［J］.眼科新进展，2018，38（4）：373-377.

相似文献/References:

[1]王怀华 曾繁星 孙晓蕾 陈秀丽 徐海峰.息肉样脉络膜血管病变的临床特征[J].眼科新进展,2013,33(3):000.
[2]彭锡嘉 王 波 苏兰萍 王登廷 郝保安 高 琛.应用荧光素吲哚青绿同步眼底造影对中心性浆液性视网膜病变眼底微循环的改变[J].眼科新进展,2009,29(1):000.
[3]童桂芳,周琼,邵毅. 急性中心性浆液性脉络膜视网膜病变FFA与频域OCT图像对比研究[J].眼科新进展,2015,35(8):735.[doi:10.13389/j.cnki.rao.2015.0201]
　TONG Gui-Fang,ZHOU Qiong,SHAO Yi. A comparative study on image of FFA and FD-OCT in acute central serous chorioretinopathy[J].Recent Advances in Ophthalmology,2015,35(8):735.[doi:10.13389/j.cnki.rao.2015.0201]
[4]佘洁婷,张国明,苏康进,等.早产儿视网膜病变注射雷珠单抗后荧光素眼底血管造影表现[J].眼科新进展,2015,35(12):1145.[doi:10.13389/j.cnki.rao.2015.0313]
　SHE Jie-Ting,ZHANG Guo-Ming,SU Kang-Jin,et al.Fundus fluorescein angiography in retinopathy of prematurity after intravitreal injection of ranibizumab[J].Recent Advances in Ophthalmology,2015,35(8):1145.[doi:10.13389/j.cnki.rao.2015.0313]
[5]王光,陈晓隆,王爱媛,等.糖尿病视网膜病变患者全视网膜激光光凝前后视网膜动、静脉循环时间的改变[J].眼科新进展,2017,37(10):962.[doi:10.13389/j.cnki.rao.2017.0244]
　WANG Guang,CHEN Xiao-Long,WANG Ai-Yuan,et al.Changes of retinal circulation time before and after panretinal laser photocoagulation in patients with diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(8):962.[doi:10.13389/j.cnki.rao.2017.0244]
[6]李士清,郭晓红,董良,等.三种类型视网膜大动脉瘤的眼底影像学特征分析[J].眼科新进展,2019,39(3):243.[doi:10.13389/j.cnki.rao.2019.0054]
　LI Shi-Qing,GUO Xiao-Hong,DONG Liang,et al.The fundus imaging features of three types of retinal arterial macroaneurysms[J].Recent Advances in Ophthalmology,2019,39(8):243.[doi:10.13389/j.cnki.rao.2019.0054]
[7]陈丛,闫明,宋艳萍.康柏西普对病理性近视脉络膜新生血管的疗效及视力预后相关性研究[J].眼科新进展,2020,40(6):569.[doi:10.13389/j.cnki.rao.2020.0131]
　CHEN Cong,YAN Ming,SONG Yanping.Efficacy of Conbercept for treatment of choroidal neovascularization with pathologic myopia and on visual prognosis[J].Recent Advances in Ophthalmology,2020,40(8):569.[doi:10.13389/j.cnki.rao.2020.0131]
[8]张万虎,刘轩,李晶明,等.OCTA与FFA在小鼠脉络膜新生血管模型中应用的比较研究[J].眼科新进展,2021,41(7):628.[doi:10.13389/j.cnki.rao.2021.0129]
　ZHANG Wanhu,LIU Xuan,LI Jingming,et al.Comparison of consistency between optical coherence tomography angiography and fundus fluorescein angiography in a mouse model of laser-induced choroidal neovascularization model[J].Recent Advances in Ophthalmology,2021,41(8):628.[doi:10.13389/j.cnki.rao.2021.0129]
[9]蔡友欢,刘洪涛,蔡瑞,等.应用炫彩成像技术观察视网膜分支静脉阻塞患者动静脉交叉压迫点的临床意义[J].眼科新进展,2021,41(10):965.[doi:10.13389/j.cnki.rao.2021.0203]
　CAI Youhuan,LIU Hongtao,CAI Rui,et al.Clinical significance of arteriovenous crossing pressure points in patients with branch retinal vein occlusion by multicolor imaging[J].Recent Advances in Ophthalmology,2021,41(8):965.[doi:10.13389/j.cnki.rao.2021.0203]
[10]文峰,苏永悦.息肉状脉络膜血管病变的新术语和非基于吲哚菁绿血管造影的诊断标准——2021亚太眼科影像学会专家共识解读与思考[J].眼科新进展,2022,42(6):421.[doi:10.13389/j.cnki.rao.2022.0086]
　WEN Feng,SU Yongyue.Interpretation of the consensus on nomenclature and non-indocyanine green angiograph based diagnostic criteria of polypoidal choroidal vasculopathy from the Asia-Pacific Ocular Imaging Society in 2021[J].Recent Advances in Ophthalmology,2022,42(8):421.[doi:10.13389/j.cnki.rao.2022.0086]
[11]王永波 石安娜 刘维锋 石浔 金昱.光动力疗法治疗渗出性年龄相关性黄斑变性的疗效观察[J].眼科新进展,2012,32(1):000.
[12]韩珺琳,张桐梅,解世勇,等.光动力疗法联合抗血管内皮生长因子治疗息肉状脉络膜血管病变的效果：基于光学相干断层扫描血管成像（OCTA）的观察[J].眼科新进展,2019,39(4):358.[doi:10.13389/j.cnki.rao.2019.0081]
　HAN Jun-Lin,ZHANG Tong-Mei,XIE Shi-Yong,et al.Observation of photodynamic laser combined with anti-vascular endothelial growth factor in the treatment of polypoidal choroidal vasculopathy with optical coherence tomography[J].Recent Advances in Ophthalmology,2019,39(8):358.[doi:10.13389/j.cnki.rao.2019.0081]
[13]李和恩,史超强,曲超.低能量810 nm激光治疗黄斑区中心性浆液性脉络膜视网膜病变的安全性及疗效[J].眼科新进展,2020,40(1):031.[doi:10.13389/j.cnki.rao.2020.0007]
　LI Heen,SHI Chaoqiang,QU Chao.Safety and efficacy of low-energy 810 nm laser in treatment of central serous chorioretinopathy in macular area[J].Recent Advances in Ophthalmology,2020,40(8):031.[doi:10.13389/j.cnki.rao.2020.0007]
[14]尹小芳,叶祖科,李国波,等.视网膜大动脉瘤的多模式影像学特征及并发症观察[J].眼科新进展,2020,40(4):348.[doi:10.13389/j.cnki.rao.2020.0080]
　YIN Xiaofang,YE Zuke,LI Guobo,et al.Clinical observation of multimodal imaging characteristics and complications of retinal arterial macroaneurysms[J].Recent Advances in Ophthalmology,2020,40(8):348.[doi:10.13389/j.cnki.rao.2020.0080]
[15]刘志强,吕丽娜,张胜娟,等.早期非典型性视网膜星形细胞错构瘤的多模式影像学特征[J].眼科新进展,2021,41(8):779.[doi:10.13389/j.cnki.rao.2021.0162]
　LIU Zhiqiang,L Lina,ZHANG Shengjuan,et al.Multimodal imaging characteristics of early atypical retinal astrocytic hamartoma[J].Recent Advances in Ophthalmology,2021,41(8):779.[doi:10.13389/j.cnki.rao.2021.0162]

备注/Memo

备注/Memo:
南昌市科技支撑计划项目（编号：2018-235-19）
更新日期/Last Update: 2019-07-31